logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

H.S. Raju

medical oncology
H指数:1
被引数:1

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world efficacy and safety of trastuzumab emtansine biosimilar (UJVIRA®) in early and metastatic HER2-positive breast cancer: a multicenter pooled retrospective analysis from India

曲妥珠单抗emtansine生物类似物(UJVIRA®)在早期和转移性HER2阳性乳腺癌中的真实世界疗效与安全性：一项来自印度的多中心合并回顾性分析

Breast Cancer Research and Treatment
IF3
2026-10-280
PRE
Ayesha Mahajan; Soumya Surath Panda; Lalatendu Moharana; M.V. Chandrakanth; Vivek Agarwala; Rupam Manna; S.V. Saju; Susan Honey Raju; Prasanth Ganesan; Gomathi Shankar; Ashwin Oommen Phillip; Sunu Lazar Cyriac; Anil Jose; P. Unnikrishnan; Kanu Priya Bhatia; Amit Sehrawat; Deepak Sundriyal; Himani Dhanai; Lipsita Samantaray; Swati Sucharita Mohanty; Biswajit Dubashi
Real-world data of PARP inhibitors in first-line maintenance for BRCA-mutated or HRD-positive advanced ovarian cancer: a multicentre retrospective study from India

PARP抑制剂在BRCA突变或HRD阳性晚期卵巢癌一线维持治疗中的真实世界数据：一项来自印度的多中心回顾性研究

Journal of Ovarian Research
IF4.2
2026-02-070
OAAI
Susheel Kumar Yeshala; Soumya Surath Panda; Lalatendu Moharana; SV Saju; Krishnakumar Rathinam; Susan Honey Raju; Amit Sehrawat; Deepak Sundriyal; Ashwin Oommen Phillip; Pamela Alice Kinsely; Kanu Priya Bhatia; Smita Kayal; Biswajit Dubashi; Sunu Lazar Cyriac; Sathya Natarajan; Lipsita Samantaray; Swati Sucharita Mohanty; Sudam Sadangi; Snehasis Pradhan; Arti Rana; Prasanth Ganesan
Real-world data of PARP inhibitors in first-line maintenance for BRCA mutated or HRD positive advanced ovarian cancer: A multicenter retrospective study from India

PARP抑制剂在BRCA突变或HRD阳性晚期卵巢癌一线维持治疗中的真实世界数据：一项来自印度的多中心回顾性研究

ANNALS OF ONCOLOGY
IF65.4
2024-12-010
PRE
Kumar, Y. S.; Panda, S. S.; Moharana, L.; Samantaray, L.; Saju, S. V.; Rathnam, K. K.; Raju, H. S.; Sehrawat, A.; Sundriyal, D.; Kingsley, P. A.; Priya, K. B.; Kayal, S.; Dubashi, B.; Philips, A. O.; Cyriac, S. L.; Natarajan, S.; Mohanty, S. S.; Ganesan, P.

研究方向

暂未获取到该数据
S
Soumya Surath Panda
H 指数:7论文数:98被引数:410
A
Amit Sehrawat
H 指数:9论文数:131被引数:257
D
Deepak Sundriyal
H 指数:11论文数:128被引数:418
K
K.K. Rathnam
H 指数:1论文数:13被引数:2
S
Swati Sucharita Mohanty
H 指数:6论文数:21被引数:267
S
Sunu Cyriac
H 指数:8论文数:64被引数:308
L
Lalatendu Moharana
H 指数:4论文数:39被引数:34
K
Kanu Priya Bhatia
H 指数:2论文数:10被引数:39
S
S. V. Saju
H 指数:4论文数:27被引数:103
S
S. Natarajan
H 指数:7论文数:49被引数:246